Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Mar
4
2019
OIG Evaluates Remote Patient Monitoring Arrangement Epstein Becker & Green, P.C.
Mar
4
2019
Five Takeaways from the Senate Finance Committee’s Hearing on Drug Pricing Mintz
Mar
4
2019
Second Circuit Rejects Total Wine Challenge of Connecticut Pricing Laws McDermott Will & Emery
Mar
4
2019
New Jersey Leaders Agree to Compromise on Cannabis Tax Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
4
2019
Final Rule Regarding the Labeling of Bioengineered Foods Polsinelli PC
Mar
4
2019
Trends from the Industrial Hemp Summit Ward and Smith, P.A.
Mar
4
2019
Supreme Court Update: Nutraceutical Corp. v. Lambert (No. 17-1094), Garza v. Idaho (No. 17-1026), Madison v. Alabama (No. 17-7505), Jam v. International Finance Corp. (No. 17-1011), Yovino v. Rizo (No. 18-272) Wiggin and Dana LLP
Mar
4
2019
Putative Class Action Filed Against Walmart, Costco, Amazon and Others Alleging Coffee is Falsely Labeled as “Kona” Keller and Heckman LLP
Mar
2
2019
The Farm Bill’s Impact on Hemp and CBD – and How Some States are Reacting Sheppard, Mullin, Richter & Hampton LLP
Mar
1
2019
March 2019: Where Are We Now With 340B? Mintz
Mar
1
2019
Analysis: How the EU legal framework is being adapted to accommodate new food proteins Keller and Heckman LLP
Mar
1
2019
This Week’s Cannabis Highlights Keller and Heckman LLP
Feb
28
2019
What Does the Future Hold for Drug Pricing? Mintz
Feb
28
2019
Nestlé’s Non-Disclosure of Child and Slave Labor Issues on Packaging Not Deceptive or Unfair, Massachusetts Federal Court Holds Proskauer Rose LLP
Feb
28
2019
Agriculture Advanced Research and Development Authority: New Program Supports Innovation in Agriculture K&L Gates
Feb
28
2019
EFSA Report Indicates Antimicrobial Resistance in EU Is Increasing Keller and Heckman LLP
Feb
27
2019
If It Ain’t Broke: Motivation to Modify Compound Must Consider All Its Characteristics McDermott Will & Emery
Feb
27
2019
ML Strategies Health Care Preview FEBRUARY 25, 2019 Mintz
Feb
27
2019
Hefty Fine is a Reminder of FCC’s Purview Over Certain Personal Hygiene and Wellness Devices Mintz
Feb
27
2019
National Milk Producers Federation Petitions FDA on Non-Dairy Alternative Labels Keller and Heckman LLP
Feb
27
2019
Gout Treatment, Uloric, Found to Pose an Increased Risk of Death Stark & Stark
Feb
27
2019
New York City Council Seeks Further Protections for Fast Food Industry Workers Jackson Lewis P.C.
Feb
26
2019
FDA Finalizes Two Guidance Documents Regarding Regenerative Medicine Therapies Epstein Becker & Green, P.C.
Feb
26
2019
FDA’s Outlines Plans to Modernize Oversight of Imported Food Keller and Heckman LLP
Feb
25
2019
Japan's Regulation of Food Contact Materials - A Step Closer to the New Positive List System Keller and Heckman LLP
Feb
25
2019
FDA Proposed Rule for OTC Sunscreen Drug Products Addresses Combination Sunscreen-Insect Repellent Products Bergeson & Campbell, P.C.
Feb
25
2019
E-cigarette Users Sue Juul Stark & Stark
Feb
25
2019
FDA Will Publish Proposed Rule for OTC Sunscreen Drug Products Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins